Intratibial Injection of Human Multiple Myeloma Cells in NOD/SCID IL-2Rγ(Null) Mice Mimics Human Myeloma and Serves as a Valuable Tool for the Development of Anticancer Strategies

• Julia Schueler,

  Affiliations Department of Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany, Department for Invivo Tumorbiology, Oncotest, Freiburg, Germany

  ⨯
• Dagmar Wider,

  Affiliation Department of Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany

  ⨯
• Kerstin Klingner,

  Affiliation Department for Invivo Tumorbiology, Oncotest, Freiburg, Germany

  ⨯
• Gabrielle M. Siegers,

  Affiliation Department of Anatomy & Cell Biology, Schulich School of Medicine, Western University, London, Ontario, Canada

  ⨯
• Annette M. May,

  Affiliation Department of Pathology, University of Freiburg Medical Center, Freiburg, Germany

  ⨯
• Ralph Wäsch,

  Affiliation Department of Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany

  ⨯
• Heinz-Herbert Fiebig,

  Affiliation Department for Invivo Tumorbiology, Oncotest, Freiburg, Germany

  ⨯
• Monika Engelhardt

  * E-mail: monika.engelhardt@uniklinik-freiburg.de

  Affiliation Department of Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany

  ⨯